BlackRock’s Edwards Lifesciences EW Stock Holding History

BlackRock’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-138,000	Closed	-$11.1M	–	5755
2026 Q1	$11.1M	Buy	+138,000	New	+$11.4M	﹤0.01%	3431
2024 Q4	–	Sell	-644,500	Closed	-$42.5M	–	5410
2024 Q3	$42.5M	Buy	+644,500	New	+$46.8M	﹤0.01%	2569
2024 Q2	–	Sell	-813,000	Closed	-$77.7M	–	5305
2024 Q1	$77.7M	Buy	+813,000	New	+$68.3M	﹤0.01%	2203
2021 Q2	–	Sell	-312,200	Closed	-$26.1M	–	5503
2021 Q1	$26.1M	Buy	+312,200	New	+$26.4M	﹤0.01%	3038
2014 Q1	–	Sell	-60,000	Closed	-$658K	–	3135
2013 Q4	$658K	Buy	+60,000	New	+$676K	﹤0.01%	1285

Other funds holding EW

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

BlackRock's EW Position: Q2 2026 in Review

BlackRock increased its Edwards Lifesciences (EW) stake by 12% in Q2 2026, buying an estimated $519M and bringing the position to 58,789,433 shares worth $5.32B. The position accounts for 0.08% of the portfolio, ranked #212.

BlackRock first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.39B in Q4 2021. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

BlackRock held 58,789,433 shares of Edwards Lifesciences worth $5.32B as of Q2 2026.
BlackRock bought 6,198,500 Edwards Lifesciences shares in Q2 2026, an estimated $519M.
Edwards Lifesciences made up 0.08% of BlackRock's portfolio in Q2 2026, its #212 holding.
BlackRock first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
BlackRock's Edwards Lifesciences position peaked at $7.39B in Q4 2021.
1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.